We have placed cookies on your computer to help make this website better. We use a PIWIK Analytics script which sets performance cookies. More details and information can be found in our cookie policy. Please refer to the privacy statement to adjust your settings for the website analytics tracking by PIWIK (e.g. deny use/opt-out).

I'm ok with this

Our unique commitment to pain | About us | Grünenthal

Our unique commitment to pain

Pain is a huge burden. It impacts patients – as well as their families, friends, caregivers and society as a whole. It is estimated that about one in five people worldwide suffers from chronic pain1, which equates to around 1.4 billion people. Pain is one of the most common reasons people seek medical help2, which places an enormous economic burden on healthcare systems. For many conditions there is no standard of care, and in cases where they do exist, they have limited efficacy3. Chronic pain is one of the major reasons why people leave the labour market prematurely, and is also a significant contributor to disability retirement4. Although few people die of pain, many still die in pain, while even more live in pain.

Given the prevalence and debilitating effects of pain, Grünenthal considers it to be a disease in its own right rather than just a symptom. As a global leader in pain management for nearly 50 years, we’re fully aware that patients are still hugely underserved in this area. We’re driven to seek new solutions to relieve pain. We are also fully committed to transforming this field. We’re redefining and shaping the future of pain management through our own research, as well as by drawing on external innovation, collaborations and networks.

1 Goldberg, D.S. and McGee, S.J., 2011, Pain as a Global Public Health Priority. BMC Public Health, 11, 770.
2 Gureje, O., Simon, G.E., Von Korff, M., 2001, A cross-national study of the course of persistent pain in primary care. Pain. 92: 195-200.
3 Pain Alliance Europe, 2017, Survey on Chronic Pain 2017, Diagnosis, Treatment and impact of Pain.
4 Saastamoinen, P. et al., 2012, Pain and disability retirement: a prospective cohort study.

Why pain matters

 

1in5

or 1.4 billion people worldwide are affected by chronic pain1

21

% of chronic pain patients suffer for more than 20 years2

78

% of chronic pain patients state that their treatment was not as good as they expected3

500

million sick days per year in Europe are due to musculoskeletal pain alone4

60

% of permanent work incapacity in Europe is due to musculoskeletal pain alone5

34

billion euros loss for the European economy due to chronic pain6

1 Goldberg, D.S. and McGee, S.J., 2011, Pain as a Global Public Health Priority. BMC Public Health, 11, 770.
2 Breivik, H. et al., Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment, European Journal of Pain 10 (2006) 287–333.
3 Pain Alliance Europe, 2017, Survey on Chronic Pain 2017, Diagnosis, Treatment and Impact of Pain.
4 Bevan, S. et al., Reducing Temporary Work Absence Through Early Intervention: The case of MSDs in the EU, 2013.
5 Bevan, S. et al., Reducing Temporary Work Absence Through Early Intervention: The case of MSDs in the EU, 2013.
6 Wiffen, P., Pain – there is a lot of it. Eur J Hosp Pharm. 2013; 20:1.